Thorazine advertisement, 1957. |
California Medicine, Vol. 87, No. 1, p. 11.
By changing the attitude of the emotional dermatologic patient, 'Thorazine'
facilitates the management of the patient and the treatment of skin disorders. The patient becomes less insistent and frantic, and accepts her affliction philosophically.
'Thorazine' does not cure skin diseases but, according to Cornbleet and Barsky,1 is a "most useful adjuvant to dermatologic therapy" in patients with an emotional background of tension, apprehension, excitement, anxiety and agitation.
'Thorazine' is available, as the hydrochloride, in 10 mg. 25 mg., 50 mg., 100 mg. and 200 mg. tablets; 25 mg. (1 cc.) and 50 mg. (2 cc.) ampuls; and syrup (10 mg./5 cc.); and, as the base, in 25 mg. and 100 mg. suppositories.
THORAZINE* "can be to the dermatologist what the anesthetist is to the surgeon."1
Smith, Kline & French Laboratories, Philadelphia
1. Cornbleet, T., and Barsky, S.: The Role of the Tranquilizing Drugs in Dermatology, presented at 115th Annual Meeting of Illinois State Medical Society, May 19, 1955.
*T.M. Reg. U.S. Pat. Off. for chlorpromazine, S.K.F.